Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
Drug Therapy01:28

Drug Therapy

246
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
246
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

927
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
927
Interpersonal Psychotherapy01:25

Interpersonal Psychotherapy

318
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
318
Depression: Overview01:18

Depression: Overview

800
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
800
Psychosurgery01:30

Psychosurgery

1.6K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies.

NPJ breast cancer·2022
Same author

Genetika+: precision medicine solutions for mental health.

Pharmacogenomics·2022
Same author

Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson's Disease.

Frontiers in pharmacology·2021
Same author

Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response.

Translational psychiatry·2021
Same author

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.

The Lancet. Digital health·2020
Same author

Associating H<sub>2</sub>O<sub>2-</sub>and NO-related changes in the proteome of Mycobacterium smegmatis with enhanced survival in macrophage.

Emerging microbes & infections·2018

Related Experiment Video

Updated: Jan 18, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.1K

Toward Precision Psychiatry: Innovations and Prospects in Treating Depression.

Daphna Laifenfeld1,2, Claudia Albeldas1, Talia Cohen Solal1

  • 1NeuroKaire Ltd, Tel Aviv, Israel.

The Primary Care Companion for CNS Disorders
|September 12, 2025
PubMed
Summary
This summary is machine-generated.

Precision medicine offers new hope for major depressive disorder, a condition affecting millions worldwide. Novel tools aim to match patients with the most effective treatments, improving outcomes and reducing trial-and-error approaches.

More Related Videos

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

293
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.3K

Related Experiment Videos

Last Updated: Jan 18, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.1K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

293
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Major depressive disorder (MDD) affects over 280 million globally, characterized by significant individual variability in treatment response.
  • Current treatment paradigms often involve a trial-and-error approach due to the complex neurobiology of depression and lack of personalized strategies.
  • Ineffective treatments lead to prolonged suffering, increased economic burden, and higher recurrence rates, highlighting the need for optimized therapeutic selection.

Purpose of the Study:

  • To review emerging precision medicine tools for depression management.
  • To explore novel approaches for tailoring antidepressant treatments to individual patient profiles.
  • To underscore the potential of these tools in improving clinical decision-making and patient outcomes.

Main Methods:

  • Review of current precision medicine technologies in depression research.
  • Discussion of pharmacogenetics, peripheral biomarkers, and neuroimaging as diagnostic and predictive tools.
  • Exploration of patient-derived neuron platforms for in vitro functional readouts.

Main Results:

  • Development of diverse precision medicine tools, including genetic testing and advanced imaging, to personalize depression treatment.
  • Emergence of in vitro platforms utilizing patient-derived neurons for predicting drug efficacy.
  • These tools offer a pathway beyond traditional trial-and-error methods for antidepressant selection.

Conclusions:

  • Novel precision medicine tools are poised to revolutionize depression management by enabling personalized treatment selection.
  • These innovations have the potential to significantly enhance therapeutic efficacy and patient well-being.
  • Guiding prescribers and patients toward optimal treatment choices is a key benefit of these advanced approaches.